Response Genetics Triples Sales Force on Growing Demand for Lung, Colon Cancer Dxs | GenomeWeb

Citing higher-than-expected sales of its lung and colon cancer tests, Response Genetics announced last week that it was tripling the size of its sales force to help market the products.

The company’s sales force will grow to 10 reps by the end of the month, and the marketing team will try to target major national markets beyond its existing presence in California, Response Genetics CEO Kathleen Danenberg told Pharmacogenomics Reporter this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.